Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-20

FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved a generic version of neostigmine methylsulfate through an original ANDA by Somerset Therapeutics, LLC. It is indicated for treatment of myasthe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)